Contents

Current Medicinal Chemistry, Volume 12 - Number 25

Editorial [Hot Topic: Latest Developments in the Treatment of Inflammatory Disease (Guest Editor: David Fairlie)]

, 12(25): 2923 - 2924

David Fairlie


DOI: 10.2174/092986705774462897




Therapeutic Targets in Inflammatory Disease

, 12(25): 2925 - 2929

David A. Hume and David P. Fairlie


DOI: 10.2174/092986705774462923




Drugs To Treat Inflammation: A Historical Introduction

, 12(25): 2931 - 2942

Michael W. Whitehouse


DOI: 10.2174/092986705774462879




Antibody Treatments of Inflammatory Arthritis

, 12(25): 2943 - 2946

Matthew A. Brown


DOI: 10.2174/092986705774462842




Anti-Inflammatory Immunotherapy for Multiple Sclerosis/Experimental Autoimmune Encephalomyelitis (EAE) Disease

, 12(25): 2947 - 2962

Jagat R. Kanwar


DOI: 10.2174/092986705774462833




Inhibitors of TACE and Caspase-1 As Anti-inflammatory Drugs

, 12(25): 2963 - 2977

Giang T. Le and Giovanni Abbenante


DOI: 10.2174/092986705774462851




MAP Kinase p38Inhibitors: Clinical Results and an Intimate Look at Their Interactions with p38α Protein

, 12(25): 2979 - 2994

Matthew R. Lee and Celia Dominguez


DOI: 10.2174/092986705774462914




PPARs in Diseases: Control Mechanisms of Inflammation

, 12(25): 2995 - 3009

Radina Kostadinova, Walter Wahli and Liliane Michalik


DOI: 10.2174/092986705774462905




Inhibitors of Secretory Phospholipase A2 Group IIA

, 12(25): 3011 - 3026

Robert C. Reid


DOI: 10.2174/092986705774462860




Nonpeptide Ligands That Target Peptide-Activated GPCRs In Inflammation

, 12(25): 3027 - 3042

Jade S. Blakeney and David P. Fairlie


DOI: 10.2174/092986705774462888




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science